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www.embomolmed.org EMBOSterile inflammation underlies many diseases of the cornea including serious
chemical burns and the common dry eye syndrome. In search for therapeutic
targets for corneal inflammation, we defined the kinetics of neutrophil infiltration
in a model of sterile injury to the cornea and identified molecular and cellular
mechanisms triggering inflammatory responses. Neutrophil infiltration occurred in
two phases: a small initial phase (Phase I) that began within 15min after injury, and
a larger secondphase (Phase II) that peaked at 24–48h. Temporal analysis suggested
that the neuropeptide secretoneurin initiated Phase I without involvement of
resident macrophages. Phase II was initiated by the small heat shock protein HSPB4
thatwas released from injured keratocytes and that activated residentmacrophages
via the TLR2/NF-kB pathway. The Phase II inflammation was responsible for vision-
threatening opacity and was markedly suppressed by different means of inhibition
of the HSPB4/TLR2/NF-kB axis: in mice lacking HSPB4 or TLR2, by antibodies to
HSPB4 or by TNF-a stimulated gene/protein 6 that CD44-dependently inhibits the
TLR2/NF-kB pathway. Therefore, our data identified the HSPB4/TLR2/NF-kB axis in
macrophages as an effective target for therapy of corneal inflammation.INTRODUCTION
Sterile inflammation is now recognized to play a key role in
many diseases that include myocardial infarction, stroke,
Alzheimer’s disease and atherosclerosis (Chen & Nun˜ez,
2010; Rock et al, 2010; Spite & Serhan, 2010). The molecular
and cellular responses of sterile inflammation include over
20 nonmicrobial endogenous stimuli referred to as damage-
associated molecular patterns (DAMPs). DAMPs signal through
pattern recognition receptors (PRRs) on resident macrophages
to activate at least three intracellular pathways to up-regulate
the expression of pro-inflammatory cytokines (Chen & Nun˜ez,ealth Science Center
SA
1 254 771 6839;
l National University
Mol Med 4, 435–4482010). In spite of the intense interest in the field, a series of
important questions has remained unanswered to date,
including whether some DAMPs identified from experiments
in vitro play important roles in vivo, whether some DAMPs play
redundant roles, and whether inflammatory responses in
different tissue involve different DAMPs that are specific for
the injured tissues (Matzinger, 2007). Therefore, to identify
therapeutic targets, it is probably essential to identify the major
DAMP or DAMPs that play essential roles in initiating sterile
inflammation in a specific disease and tissue.
The cornea is an attractive system to investigate sterile
inflammation since it is readily accessible to experimental
manipulations in vivo and in vitro. Moreover, sterile inflamma-
tion underlies many diseases of the cornea that include vision-
threatening conditions such as chemical burns and quality-of-life-
deteriorating diseases such as dry eye syndrome (Moss et al,
2008; Wagoner, 1997). To search for novel therapeutic targets
for sterile inflammation, we adopted a model of chemical and
mechanical injury inwhich the corneawas injured by exposure to
ethanol and mechanical scraping to remove both the epithelium 2012 EMBO Molecular Medicine 435
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436and limbal stem cells. We first defined the kinetics of neutrophil
infiltration and then examined the temporal sequence of genes
expressed in the cornea to identify factors that triggered the
infiltration of neutrophils into the cornea. We observed that the
injury provoked two distinct phases of neutrophil infiltration: a
small initial phase (Phase I) that beganwithin 15min and reached
a plateau between 4 and 8h and a much larger second phase
(Phase II) that peaked at 24–48h. Analysis of the two phases
demonstrated that Phase I was stimulated by the neuropeptide
secretoneurin (SN). The second, more massive infiltration of
neutrophils in Phase II was stimulated by the small heat shock
protein HSPB4 that was synthesized and released by injured
keratocytes of the corneal stroma and that acted as a DAMP
to activate resident macrophages through the TLR2/NF-kB
signalling pathway. The inflammatory response in Phase II
was largely responsible for vision-threatening opacity. Phase II
was dramatically suppressed by inhibition of the HSPB4/TLR2/
NF-kB axis in resident macrophages: (i) by depletion of resident
macrophages, (ii) by administration of antibodies to HSPB4,
(iii) in mice lacking HSPB4, (iv) in mice lacking TLR2 or (v) by
administration of TNF-a stimulated gene/protein 6 (TSG-6)
that inhibits TLR2/NF-kB signalling in macrophages in a
CD44-dependent manner.RESULTS
Two phases of neutrophil infiltration after sterile injury
to the cornea
We injured the corneas of Lewis rats by exposing them to 100%
ethanol for 30 s and scraping of the cornea and limbus toFigure 1. Time course of cellular and molecular changes in the rat cornea af
A. Time course of neutrophil infiltration in the cornea as measured by MPO. Neut
began within 15min and reached a plateau level at 4–8 h; Phase II, a larger infi
gradually decreased over 7 days that reflected the recovery phase. n¼5 at e
B. Microarray data of the cornea at 0, 4 and 24 h after sterile injury. The up-reg
regulated at 4 h and returned towards normal at 24 h; Group B, genes that we
gradually up-regulated over 24 h in parallel with neutrophil infiltration. n¼ 4
C. Real-time RT PCR assays of representative genes in Groups A, B and C. n¼ 5
 2012 EMBO Molecular Medicineremove both the epithelium and limbal stem cells. Most of the
infiltrating cells in the cornea were neutrophils early after
ethanol/scraping injury as shown in our previous experiments
(Oh et al, 2010). Thus, we followed neutrophil infiltration
by assays for myeloperoxidase (MPO) that is stored within
neutrophil granules (Borregaard & Cowland, 1997). The
neutrophil infiltration occurred in two phases. There was a
small initial phase that began within 15min and reached a
plateau level at 4–8 h (Phase I in Fig 1A). After the plateau,
a much larger infiltration of neutrophils followed and
reached a maximum at 24–48 h (Phase II in Fig 1A). The
neutrophils then gradually disappeared in a recovery phase
over 48 h to 7 days.
Search for candidate stimuli for Phase I and Phase II
As a strategy to identify candidate stimuli that initiated the two
phases, we used microarrays to survey the response of the
cornea to injury. We focused our attention on the genes up-
regulated early after an injury under the assumption that the
molecules up-regulated in the tissues in response to an injury
might act as the major stimuli to initiate the sterile inflamma-
tion. Based on the temporal pattern of gene expression, we
classified the up-regulated genes into the following three groups
(Fig 1B, Supporting Information Fig S1): Group A, genes that
were up-regulated at 4 h and returned towards normal at 24 h;
Group B, genes that were up-regulated at 4 h and remained
steady at 24 h; and Group C, genes that were gradually up-
regulated over 24 h in parallel with neutrophil infiltration. A
total of 842 genes were up-regulated in Group A, 108 genes were
up-regulated in Group B and 307 genes were up-regulated in
Group C (Supporting Information Fig S1). We focused on theter sterile injury.
rophils infiltrated the cornea in two phases: Phase I, a small initial phase that
ltration of neutrophils that followed and peaked at 24–48 h. Then neutrophils
ach time-point.
ulated genes were classified into three groups: Group A, genes that were up-
re up-regulated at 4 h and remained steady at 24 h; Group C, genes that were
at each time-point.
per group at each time-point. Error bars represent means s.e.m.
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Figure 2.
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438Group A genes because they were expressed earlier and thus
more likely to include stimuli for Phase I and II (Fig 1C). Most of
the Group A genes were transcripts for nerve/neurotransmis-
sion-related proteins and structural proteins of the eye
(Supporting Information Table S1 and Fig S1). Most of the
Group B genes were the molecules related to apoptosis/death
and defense response (Supporting Information Table S1 and
Fig S1). Most of Group C molecules were pro-inflammatory
chemokines and cytokines (Supporting Information Table S1
and Fig S1) that peaked late in the inflammatory responses
(Supporting Information Fig S2). From the category of Group A
genes, we selected the following as attractive candidates for
inflammatory signals: (i) the neuropeptide SN because it is
stored in nerve endings (Troger et al, 2005) and was previously
shown to activate the chemotactic migration and transendothe-
lial extravasation of blood cells (Helle, 2010; Taupenot et al,
2003) and (ii) two small heat shock proteins, HSPB4 and HSPB5,
because some heat shock proteins (HSPs) were previously
shown to act as DAMPs (Henderson & Pockley, 2010; Joly et al,
2010; Quintana & Cohen, 2005; van Wijk & Prakken, 2010).
SN as a candidate stimulus for Phase I and HSPB4 for Phase II
Data on the time course of expression were consistent with SN
serving as an initiating stimulus for Phase I. SNwas not detected
in extracts of uninjured cornea or the serum, but it appeared
both in corneal extracts and the serum of the rats within 0.25 h of
the injury (Fig 2A and C). The levels of SN in extracts of injured
cornea and the serum decreased temporarily at 0.5 h after the
initial release and then increased again at 2 h apparently as a
result of increased expression of the gene (Fig 2A, C, F and H).
We measured the levels of SN in the serum in order to evaluate
the levels of SN released outside of corneal nerve endings in
response to an injury as a distinct form, not SN stored inside
sensory nerve endings in the cornea (Troger et al, 2005). Since
the expression pattern of SN in the serum after injury
corresponded with that of SN in the cornea, the results
suggested that the source of SN in the serum after corneal
injury was the sensory nerve endings in the injured cornea. In
fact, immunohistochemistry of injured cornea showed an
increased expression of SN along the nerves in the posterior
corneal stroma at 2 h following injury (Fig 2F).
On the other hand, there were little changes in the expression
of genes for substance P and calcitonin gene-related peptideFigure 2. Increased expression of SN and HSPB4 in the rat cornea and kerato
A,B. Western blots of SN and HSPB4 in the cornea. SN was immediately released i
peak at 4 h.
C. SN was increased in the blood of injured rats in the same temporal sequence
means s.e.m.
D. HSPB4 increased rapidly in the cornea after injury with a peak at 4 h. n¼5
E. HSPB4 was released from injured cornea to the media during incubation in cu
F,G. Immunohistochemistry of the cornea after injury demonstrated increases o
H,I. Real-time RT PCR assays of selected Group A genes (neuropeptides, small HSP
represent meansþ s.e.m.
J. Real-time RT PCR assays of selected Group A genes (small HSPs and crystallin
Error bars represent meansþ s.e.m.
K. Assays for aconitase activity in the injured cornea as a measure for ROS. n
L. Keratocytes expressed HSPB4 in response to incubation with H2O2 to gener
 2012 EMBO Molecular Medicine(CGRP), two other neuropeptides known to be expressed
abundantly in the cornea (Fig 2H; Troger et al, 2007).
Similar data on the time course of expression were consistent
with HSPB4 serving as a stimulus for Phase II. Uninjured cornea
contained low levels of HSPB4 protein, but the amount
increased beginning after 0.5 h of the injury and reached a
peak at 4 h (Fig 2B, D, and G). A similar time course was
observed in the release of HSPB4 into the medium in
experiments in which cornea was injured in vivo and then
incubated ex vivo (Fig 2E). As expected from the microarray
data, real-time RT PCR assays demonstrated increased expres-
sion of mRNAs for HSPB4 and related genes from Group A
(Fig 2I). However, the increases in expression of HSPB4 were
delayed compared to the increase in the mRNA for SN
(compare Fig 2H and I). Immunohistochemistry of injured
cornea was consistent with these results. The expression of
HSPB4 in the corneal stroma was increased at 4 h following
injury (Fig 2G).
Keratocytes in the corneal stroma released HSBP4 in
response to injury
To define the cellular origin of HSPB4 in the injured cornea,
keratocytes, that are fibroblast-like cells from the corneal
stroma, were incubated with extracts of the cornea in which
necrosis was induced by homogenization and repeated cycles of
freezing–thawing. The necrotic extracts induced the expression
of HSPB4 in keratocytes (Fig 2J). The necrotic extracts,
however, did not significantly increase the expression of a
second small HSP, HSPB5 or a third Group A gene, bB-crystallin,
in keratocytes. Most of sterile inflammation accompanies the
generation of reactive oxygen species (ROS) (Martinon, 2007;
Naik & Dixit, 2011). As expected, assays of injured cornea
demonstrated a rapid decrease in aconitase activity, a reflection
of an increase in ROS (Fig 2K). The incubation of keratocytes
with H2O2 to increase ROS resulted in increased expression of
HSPB4 in keratocytes (Fig 2L). Therefore, the results suggested
that injury to the cornea generated ROS, and an increase in ROS
stimulated keratocytes to synthesize HSPB4.
SN stimulated neutrophil infiltration of Phase I, and HSB4
stimulated Phase II
Injection of recombinant SN (0.2 ng corresponding to the
amount of SN detected by ELISA in the rat cornea at 15min aftercytes after sterile injury.
nto the cornea after injury. HSPB4 rapidly increased after injury and reached a
as its expression in the cornea. n¼ 5 at each time-point. Error bars represent
at each time-point. Error bars represent means s.e.m.
lture. n¼5 per group at each time-point. Error bars represent means s.e.m.
f SN within 2 h and increases of HSPB4 within 4 h.
s and crystallins) in the cornea. n¼5 per group at each time-point. Error bars
s) in keratocytes incubated with extracts of necrotic cornea. n¼ 5 per group.
¼5 at each time-point. Error bars represent means s.e.m.
ate ROS. n¼5 per group. Error bars represent meansþ s.e.m. HSPB.
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Figure 3. SN reproduced the Phase I inflammatory response and HSPB4 reproduced Phase II.
A. The injection of the recombinant SN (0.2 ng) into the corneal stroma of rats reproduced Phase I, but not Phase II. n¼5 per group at each time-point. p values,
versus control (PBS-treated). Error bars represent means s.e.m.
B. Injection of the recombinant HSPB4 (100 ng) into the corneal stroma reproduced Phase I and Phase II. n¼5 per group at each time point. p values,
versus control (PBS-treated). Error bars represent means s.e.m.
C. The corneal opacity developed around the injection site (arrows) of HSPB4 (100 ng) 24 h after injection (top panels). Sections were stained with H&E or
immunostained for neutrophil elastase. Increased neutrophil infiltration was observed around the site of HSPB4 injection (arrows) (middle and bottom
panels).
D. Topical administration of a calcium channel blocker (Diltiazem) 15min prior to injury significantly decreased Phase I neutrophil infiltration in the cornea after
sterile injury. n¼5 per group. Error bars represent meansþ s.e.m.
E. Subconjunctival injection of either polyclonal (pAb) or monoclonal (mAb) antibodies to HSPB4 significantly decreased Phase II neutrophil infiltration in the
cornea after sterile injury. n¼5 per group. Error bars represent meansþ s.e.m.
F. HSPB4-knockout mice (Hspb4/) developed significantly less Phase II inflammatory response in the cornea after sterile injury than wild-type control mice
(129S6/SvEvTac). n¼8 per group. Error bars represent meansþ s.e.m.injury) into the stroma of the cornea stimulated the neutrophil
infiltration of Phase I, but not Phase II (Fig 3A). The effect of SN
injection was concentration-dependent. The injection of 1 ng SN
significantly increased the amount of MPO in the cornea
(Supporting Information Fig S3). The Phase I response was
partially negated in the cornea after chemical/mechanical injury
by topical application of a calcium channel blocker Diltiazem
(Fig 3D) that inhibits the release of neuropeptides (Gonzalez
et al, 1993). The results, therefore, indicated that SN served as a
major stimulus for Phase I, although they did not exclude the
possibility that SN acted in concert with other signals released
by the injured cornea.www.embomolmed.org EMBO Mol Med 4, 435–448An intrastromal injection of recombinant HSPB4 (100ng,
which corresponded to the amount of HSPB4 detected by ELISA
in the rat cornea at 15min after injury) that was pyrogen-free
(see Materials and Methods section) stimulated the neutrophil
infiltration of both Phase I and Phase II (Fig 3B and C).
Reproduction of Phase I by HSPB4 injection was partly explained
by the protein being injected earlier than it appeared in the
tissue by the injury to the cornea (Fig 2B, D, E and G). Injection
of recombinant HSPB4 also reproduced the corneal opacity
and neutrophil infiltrates that were localized around the site
of injection (Fig 3C). To confirm that the effect of HSPB4
injection was specific to HSPB4, we also injected HSPB5 having 2012 EMBO Molecular Medicine 439
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440a similar molecular weight (23 kDa) to HSPB4. HSPB5 did not
induce a significant change in MPO compared to PBS injection
(Supporting Information Fig S4). The role of HSPB4 was
confirmed by experiments in which antibodies to the protein
were injected into the subconjunctival space immediately
after chemical/mechanical injury was made to the cornea.
The antibodies to HSPB4 significantly inhibited the Phase II
inflammatory response in the cornea after the injury (Fig 3E).
In addition, the neutrophil infiltration of Phase II in the cornea
after the injury was significantly decreased in the corneas of
HSPB4 knockout mice compared to their wild-type controls
(Fig 3F).
HSPB4 induced Phase II by activating resident macrophages
through TLR2/NF-kB signalling
To identify the cells that responded to HSPB4 in the cornea, we
depleted resident macrophages from the cornea of rats by
subconjunctivally injecting clodronate liposome and then
injected recombinant HSPB4 into the corneal stroma. Macro-
phage depletion was confirmed with immunostaining for the
macrophage-specific markers CD68 and CD11b (Supporting
Information Fig S5). The inflammation was markedly decreased
in the cornea after chemical/mechanical injury when resident
macrophages were depleted prior to an injury (Fig 4), indicating
a crucial role of resident macrophages in sterile injury-induced
inflammation of the cornea. Similarly, HSPB4 did not reproduce
Phase II in rats in which macrophages were depleted (Fig 5A),
suggesting that the effects of HSPB4 were dependent on the
presence of resident macrophages. In parallel experiments, we
observed that Phase II, but not Phase I, was significantly
suppressed in the cornea after sterile injury by an intraocularFigure 4. Sterile injury-induced inflammation was markedly decreased in the
A-C. Sterile injury was made to the rat cornea after resident macrophages were
(Cl2MDP-LIP) on day 2 (2 days before injury) and day 0 (immediately after i
(A), H&E staining (B) and immunostaining for neutrophil elastase to identif
decreased in the cornea 24 h after injury by injection with clodronate-encap
(PBS-LIP). n¼5 per group at each time-point. p values, versus control (PBS-L
markedly decreased in the macrophage-depleted cornea. Error bars represe
 2012 EMBO Molecular Medicineinjection of the anti-inflammatory protein TSG-6 (Fig 5B) that
inhibits TLR2/NF-kB signalling in macrophages (Choi et al,
2011; Lesley et al, 2004). Also, TSG-6 significantly suppressed
the Phase II inflammatory response caused by an intrastromal
injection of HSPB4 (Fig 5C). Furthermore, the HSPB4-induced
inflammatory response in Phase II was significantly decreased in
the corneas of TLR2 knockout mice, compared to wild-type
control mice (Fig 5D). The results, therefore, suggested that
HSPB4 induced Phase II by activating TLR2/NF-kB signalling in
resident macrophages.
To test the effect of HSPB4 on macrophages, macrophages in
culture were incubated with extracts of necrotic corneas. The
necrotic extracts increased the expression of the pro-inflamma-
tory cytokines IL-1a, IL-1b and IL-6 in macrophages (Fig 5E).
However, heat inactivation of the extracts completely abrogated
the effect of necrotic extracts on macrophages, suggesting that
the macrophage-activating factor(s) in the necrotic cornea
was protein(s). Addition of either polyclonal or monoclonal
antibodies to HSPB4 significantly suppressed the effect of the
necrotic extracts on macrophage activation, indicating that one
of the active factor(s) in the necrotic cornea was HSPB4 (Fig 5E).
Also, recombinant HSPB4 increased the expression of the pro-
inflammatory cytokines by macrophages in a concentration-
dependent manner (Fig 5F). In addition, HSPB4 caused
translocation to the nucleus of the NF-kB complex in
macrophages (Fig 5G). To test whether HSPB4 signalled
through the TLR2/NF-kB pathway, we used a reporter cell line
transfected to assay the TLR2-mediated activation of the NF-kB
signalling (HEK-TLR2). Experiments in a HEK-TLR2 cell line
demonstrated that the necrotic extracts of the cornea increased
TLR2/NF-kB signalling and that antibodies to HSPB4 inhibitedcornea after depletion of resident macrophages.
depleted by subconjunctival injections of clodronate-encapsulated liposome
njury). The cornea was evaluated for neutrophil infiltration by assays for MPO
y neutrophils (C). (A) Neutrophil infiltration measured by MPO was markedly
sulated liposome, compared to PBS-encapsulated liposome-injected controls
IP-treated). Infiltration of inflammatory cells (B) and neutrophils (C) was also
nt meansþ s.e.m.
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Figure 5. HSPB4 induced the Phase II inflammatory response by activating resident macrophages through TLR2/NF-kB signalling.
A. Intrastromal injection of HSPB4 (100 ng) did not induce the Phase II response when corneal macrophages were depleted by subconjunctival injection of
clodronate-encapsulated liposome (Cl2MDP-LIP). n¼5 per group at each time point. p values, versus control (PBS-LIP-treated). Error bars represent
means s.e.m.
B. Sterile injury to the cornea did not induce Phase II after intraocular injection of TSG-6 (2mg), an inhibitor of TLR2/NF-kB signalling in resident macrophages.
n¼5 per group at each time point. p values, versus control (PBS-treated). Error bars represent means s.e.m.
C. Intraocular injection of TSG-6 (2mg) significantly suppressed the HSPB4-induced neutrophil infiltration in the cornea at 24 h after injury, suggesting the
importance of TLR2/NF-kB signalling in the action of HSPB4. n¼5 per group. Error bars represent meansþ s.e.m.
D. Also, HSPB4 induced significantly lower infiltration of neutrophils in the cornea of TLR2 knockout mice (TLR2/) at 24 h after injury (n¼ 4 per group), which
demonstrated that HSPB4 primarily acted through TLR2. Error bars represent meansþ s.e.m.
E. Necrotic corneal extracts, but not heat-treated extracts, activated macrophages in culture to express pro-inflammatory cytokines. Treatment with polyclonal
(pAb) or monoclonal (mAb) antibodies to HSPB4 significantly reduced macrophage activation by necrotic extracts, suggesting that HSPB4 in the extracts was
responsible for effects on macrophage activation. n¼6 per group. p values, versus necrotic extracts-treated and antibody-untreated group. Error bars
represent meansþ s.e.m.
F. Activation of macrophages by recombinant HSPB4 was concentration-dependent. n¼ 6 per group. p values, versus no HSPB4 treatment. Error bars represent
meansþ s.e.m.
G. Recombinant HSPB4 caused nuclear translocation of the NF-kB complex in macrophages.
H. Necrotic corneal extracts stimulated the TLR2/NF-kB pathway in cells expressing TLR2 (HEK-TLR2). Antibodies to HSPB4 significantly inhibited the effects.
n¼6 per group. Error bars represent meansþ s.e.m.
I,J. HSPB4 concentration-dependently stimulated NF-kB signalling in cells expressing TLR2, but had no effect in cells without either receptor (HEK-null). n¼6 per
group. p values, versus no HSPB4 treatment. Error bars represent meansþ s.e.m.the effect (Fig 5H). Recombinant HSPB4 stimulated the NF-kB
signalling in the same cell line in a concentration-dependent
manner (Fig 5I). HSPB4 had no effect on the reporter cell line
without either receptor (Fig 5J). Of note, other Group Awww.embomolmed.org EMBO Mol Med 4, 435–448molecules such as HSPB5 and bB-crystallin had no effect on pro-
inflammatory cytokine production in macrophages or on NF-kB
activation in HEK-TLR2 cells (Supporting Information Fig S6).
Also, SN did not induce the expression of pro-inflammatory 2012 EMBO Molecular Medicine 441
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Figure 6. TSG-6 inhibition of HSPB4-activated macrophages and the requirement for CD44.
A,B. Dose-dependent suppression by TSG-6 of macrophages activated by HSPB4. n¼6 per group. p values, versus PBS treatment. Error bars represent
meansþ s.e.m.
C. TSG-6 had no effect on NF-kB signalling in HEK-TLR2 cells that did not express CD44. n¼ 8 per group. Error bars represent meansþ s.e.m.
D. Inhibition by TSG-6 of NF-kB signalling in HEK-TLR2 cells expressing CD44. n¼ 8 per group. Error bars represent meansþ s.e.m.
E. TSG-6 did not suppress the inflammatory response at 24h after injury in transgenic mice with null alleles for CD44 (CD44/), whereas TSG-6 significantly
inhibited inflammation in the cornea of wild-type mice expressing CD44 (C57B/6). n¼ 10 per group. Error bars represent meansþ s.e.m.
442cytokines in either macrophages or keratocytes in culture
(Supporting Information Fig S7). Similarly, HSPB4 did not
stimulate keratocytes in culture to express pro-inflammatory
cytokines (Supporting Information Fig S7).
Together, the results indicated that HSPB4 was a principal
DAMP for Phase II inflammation and acted through the
activation of resident macrophages in the cornea.
TSG-6 suppressed HSPB4-induced activation of macrophages
in a CD44-dependent manner
Based on the observation that TSG-6 suppressed Phase II, not
Phase I (Fig 5B and C), we tested the hypothesis that TSG-6
might suppress the HSPB4-induced activation of macrophages.
We found that an addition of recombinant TSG-6 decreased the
expression of pro-inflammatory cytokines in macrophages that
were stimulated by HSPB4 (Fig 6A and B). Since the protein was
previously shown to inhibit TLR2/NF-kB signalling in macro-
phages by interaction with CD44 on macrophages (Choi et al,
2011; Lesley et al, 2004), we examined whether the effects of 2012 EMBO Molecular MedicineTSG-6 was CD44-dependent. As a result, recombinant TSG-6
decreased NF-kB signalling in the HEK-TLR2 reporter cells
stably expressing CD44 (Fig 6C and D). However, TSG-6 had no
effect on the parent cell line that did not express CD44. Also,
TSG-6 had no effect on the Phase II inflammatory response after
chemical/mechanical injury to the cornea of CD44 knockout
mice (Fig 6E), indicating that the action of TSG-6 was CD44-
dependent. Together, TSG-6 interacted with CD44 on macro-
phages and thereby decreased the activation of TLR2/NF-kB
signalling that had been induced by HSPB4 released from
injured cornea.DISCUSSION
As summarized in Fig 7, the results demonstrated that there
were two distinct phases of neutrophil infiltration in the cornea
after sterile injury: (i) a small initial Phase I that began within
15min and reached a plateau level in 4–8 h and (ii) a muchEMBO Mol Med 4, 435–448 www.embomolmed.org
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Figure 7. Graphic summary of sterile inflammation in the cornea. Immediately after injury, SN is released from nerve endings in the cornea to recruit
circulating neutrophils and induce an initial inflammatory response (Phase I). Then necrotic or injured keratocytes release HSPB4 in response to injury and
oxidative stress. The HSPB4 activates resident macrophages in the cornea via TLR2/NF-kB signalling pathway to produce pro-inflammatory cytokines including IL-
1 and IL-6. The pro-inflammatory signals released by resident macrophages are amplified by keratocytes that produce chemokines to further recruit large amount
of neutrophils (Phase II). TSG-6 inhibits the initial activation of resident macrophages by modulating TLR2/CD44/NF-kB signalling and thereby decreases the
Phase II inflammatory response.larger Phase II with a peak at 24–48 h. In search for the stimuli
for Phase I and II responses, we screened for the molecules up-
regulated in the cornea in each phase after an injury on the
assumption that the molecules produced actively by tissues in
response to an injury might act as the major stimuli to initiate
the sterile inflammation.
The major stimulus for the Phase I response was the
neuropeptide SN. Intrastromal injection of recombinant SN
reproduced the Phase I response, and an inhibitor of the release
of neuropeptides blocked the effect. As indicated by experiments
withmacrophage depletion, Phase I did not require participation
of resident macrophages. SN did not elicit the further, intense
infiltration of neutrophils in Phase II that was mediated by
activation of resident macrophages. Therefore, the Phase I
response was independent of the Phase II response and was not
severe enough to cause corneal opacity occluding the visual
axis. Nevertheless, neuropeptides are attractive candidates for
the stimuli for the initial rapid inflammatory responses of the
tissues because they are preformed and rapidly released from
nerve endings by injury. Neuropeptides may be particularly
important in the response of the cornea to an injury since the
cornea is one of the most heavily innervated tissues in the
body (Nishida, 2005). SN is a member of the granin family ofwww.embomolmed.org EMBO Mol Med 4, 435–448neuropeptides/neurotransmitters that contributes to innate
immunity by activating chemotactic migration and transen-
dothelial extravasation of immune cells (Troger et al, 2005;
Helle, 2010). Importantly, SN was shown to be as effective as
TNF-a in stimulating transmigration of neutrophils through an
endothelial cell barrier (Ka¨hler et al, 2001, 2002). Also, recent
in vivo studies suggested that SN has an important role in
common diseases such as myocardial infarction, rheumatoid
diseases, or acute inflammatory bowel syndromes (Helle, 2010;
Taupenot et al, 2003; Wiedermann, 2000).
The data demonstrated that the small heat shock protein
HSPB4 was the principal stimulus for the Phase II response that
is largely responsible for vision-threatening opacity of the
cornea. Injury to the cornea actively released HSPB4. Addition
of necrotic extracts from corneal tissues increased the synthesis
of HSPB4 by stromal keratocytes, probably as a result of
increased ROS and other stimuli in the necrotic cornea. HSPB4
free of pyrogens reproduced the Phase II response by activating
resident macrophages via the TLR2/NF-kB signalling pathway.
HSPB4 did not induce Phase II in the corneas depleted of
resident macrophages. In culture, HSPB4 stimulated the TLR2/
NF-kB signalling in macrophages to release a cascade of pro-
inflammatory cytokines such as IL-1a and IL-1b. The critical 2012 EMBO Molecular Medicine 443
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444role of the HSPB4/TLR2/NF-kB axis in macrophages was
confirmed by the observation that the intense inflammatory
response in Phase II in injured cornea was greatly diminished by
depletion of resident macrophages, by blocking HSPB4 with
antibodies to HSPB4, in mice lacking HSPB4 or TLR2, or by
administration of TSG-6 that inhibits TLR2/NF-kB signalling in
macrophages in a CD44-dependent manner (Choi et al, 2011;
Lesley et al, 2004).
The role of HSPB4 as a DAMP is consistent with previous
observations with other HSPs such as HSP60, 70, 72 or 96 (Asea
et al, 2000; Chen & Cao, 2010; Huang et al, 2009; Lehnardt et al,
2008;Wheeler et al, 2009). HSPB4 is amember of smallmolecular
weight HSPs (small HSPs) that range in size from 15 to 30kDa.
Like other HSPs, small HSPs are induced by heat and other stimuli
such as oxidative and inflammatory stresses, and they act as a
chaperone to protect cells from damage produced by misfolded
proteins. However, HSPs have paradoxical effects (Chen et al,
2007a; DeMeester et al, 2001; Kobba et al, 2011). Heat shock pre-
treatment induces intracellular HSPs to protect against inflam-
mation, whereas after inflammatory injury has been primed or
cell integrity has been compromised, heat shock induces the
release of HSPs from damaged or stressed cells and exacerbates
the cell injury. Furthermore, HSPs are known to facilitate the
binding of other danger signals to immune cells and thus to
enhance the immunogenicity (Chen & Cao, 2010). Consistent
with these reports, we for the first time report here that a small
HSP, HSPB4, stimulated macrophages in vitro through the TLR2/
NF-kB pathway and acted as the principal DAMP in vivo for
the Phase II inflammatory response in the injured cornea.
In contrast, another small HSP, HSPB5, did not induce this
response.
The identification of the HSPB4/TLR2/NF-kB axis in resident
macrophages as the principal stimuli for the Phase II inflamma-
tory response has several implications for potential therapies.
One is that the results provide novel therapeutic targets for
diseases of the corneal surface that are characterized by sterile
inflammation and for which there currently are no effective
therapies. The results suggest that modulating the HSPB4/TLR2/
NF-kB axis with antibodies/antagonists to HSPB4 or with
recombinant TSG-6may be beneficial for over 500,000Americans
who sustain chemical injuries of the cornea each year. The results
also provide a basis for developing therapies for other diseases of
the eye or of other tissues. HSPB4 was up-regulated in the retina
in models for uveitis (Rao et al, 2008; Saraswathy et al, 2010),
glaucoma (Munemasa et al, 2009), age-related macular degen-
eration (Kapphahn et al, 2003) and hypoxic retinopathy (Miyara
et al, 2008). Also, HSPB4 is expressed in nonocular tissues such
as spleen, thymus, pancreas and kidney (Deng et al, 2010;
Srinivasan et al, 1992). Therefore, the strategy of using TSG-6 or
antibodies/antagonists to extracellular HSPs may present useful
to treat a variety of inflammatory diseases where HSPs are the
primary signals for inflammation such as ischemia-reperfusion
injury (Gill et al, 2010). Still another implication of the results is
that the strategy of usingmicroarrays to follow the response of the
tissue to injury may be useful to analyse the inflammatory
responses and to identify therapeutic targets for inflammatory
diseases of other tissues or organs. 2012 EMBO Molecular MedicineMATERIALS AND METHODS
Animals
Lewis rats (LEW/Crl) were purchased from Charles River Laboratory
(Wilmington, MA). HSPB4 knockout mice (Cryaa/ or Hspb4/)
were generated at the National Eye Institute by targeted gene
disruption and were maintained in the 129S6/SvEvTac background
(Brady et al, 1997). 129S6/SvEvTac mice were purchased from Taconic
Farms, Inc. (Germantown, NY). TLR-2 knockout mice (B6.129-
Tlr2tm1Kir/J), CD44 knockout mice (CD44/; B6.Cg-Cd44tm1Hbg/J)
and C57BL/6J were obtained from Jackson Laboratory (Bar Harbor,
ME). All animals were used under a protocol approved by the
Institutional Animal Care and Use Committee of Texas A&M Health
Science Center College of Medicine.
Animal models of injury and treatment
Injury was created by applying 100% ethanol to the whole cornea
including the limbus for 30 s followed by rinsing with 1ml of balanced
salt solution. Then the whole corneal and limbal epithelium was
mechanically scraped using a surgical blade.
For injection of the recombinant human (rh) SN (PolyPeptide
Laboratories, Hillerød, Denmark) or HSPB4 (Enzo Life Sciences,
Plymouth Meeting, PA), proteins in 2ml PBS (0.2 ng SN or 100 ng
HSPB4 which corresponded to the amounts of SN or HSPB4 detected
by ELISA in the rat cornea at 15min after injury) were injected using a
32 gauge needle into the corneal stroma near the temporal limbus of
the rat eyes. To confirm that the effect of HSPB4 injection was HSPB4-
specific rather than an effect of recombinant protein, we also injected
HSPB5 (100 ng/2ml PBS, Enzo Life Sciences) having a similar
molecular weight (23 kDa) to HSPB4 into the corneal stroma. For
experiment in TLR2 knockout mice, 10 ng HSPB4 in 1ml PBS or the
same volume of PBS was injected into the corneal stroma of the
mouse eyes. The proteins were sterilized prior to use. HSPB4 was
purified by endotoxin binding columns according to the manufac-
turer’s instructions (EndoClear, blue, Hycult Biotech Inc., Plymouth
Meeting, PA) and tested to be free of detectable levels of Gram-
negative bacterial endotoxins (<0.01 EU/ml) and proteins (<1ng/ml)
using the Limulus amoebocyte lysate kit (Hycult Biotech Inc.) and
Escherichia coli HCP ELISA kit (Cygnus Technologies, Southport, NC).
For blocking the release of SN from nerve endings in the cornea, 20ml
of 2mM Diltiazem solution in isotonic saline (Sigma–Aldrich, St. Louis,
MO) was topically applied to the rat cornea 15min prior to injury
(Gonzalez et al, 1993). The blockage of SN release by Diltiazem
instillation was confirmed by evaluating the serum level of SN after
injury. For blocking HSPB4 in the cornea, either mouse monoclonal or
rabbit polyclonal antibodies to rat HSPB4 (10 or 50mg in 100ml PBS)
(ab14821 and ab5595, Abcam, Cambridge, MA) were subconjunctiv-
ally injected near the limbus immediately before the injury. The same
concentration of isotype IgG was injected as control. The antibodies
were sterilized prior to injection.
For macrophage depletion, either 100ml of clodronate-encapsulated
liposome (5mg clodronate/ml, Encapsula Nano Sciences, Nashville,
TN) or the same volume of PBS-encapsulated liposome (Encapsula
Nano Sciences) was injected into the subconjunctival space near the
limbus on day 2 (2 days before injury) and on day 0 (day of injury).
The injection was evenly dispensed over four quadrants (25ml each)
so that a circular bleb around the cornea was formed.EMBO Mol Med 4, 435–448 www.embomolmed.org
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6 (2mg in 5mL of PBS) (2104-TS, R&D Systems, Minneapolis, MN) or
the same volume of PBS was injected into the anterior chamber of the
rat eye immediately after injury. We used 2mg TSG-6 because this was
the maximal and the most effective dose as we previously
demonstrated (Oh et al, 2010).
Cells and cell lines
Murine macrophages (RAW 264.7) were obtained from ATCC
(Rockville, MD). Human embryonic kidney (HEK) 293 cells that
expressed TLR2 or TLR4 with secreted alkaline phosphatase driven
by an NF-kB promoter were purchased from InvivoGen (HEK-BlueTM
-hTLR2 and HEK-BlueTM -hTLR4, San Diego, CA). Control cell line not
expressing either TLR2 or TLR4 was also obtained (HEK-BlueTM -Null1,
InvivoGen). Primary human keratocytes were obtained from ScienCell
(Carlsbad, CA) and used at passage 5.
The stable cell line expressing human CD44 was generated in HEK-
BlueTM -hTLR2 cells. The CD44 coding sequence (Origene, Rockville,
MD) was inserted into the plasmid pcDNA 3.1 (Invitrogen, Carlsbad,
CA) using Not1/Xba1 sites and the plasmid (pcDNA 3.1-CD44)
transformed into E. coli (Subcloning EfficiencyTM DH5aTM Competent
Cells; Invitrogen) for cloning. The transfected cells were lifted by
pipetting and plated in four 10 cm culture dishes in 10ml of growth
medium supplemented with 1 HEK-BlueTM Selection media (Invivo-
Gen). The cells were kept in the selection media for 2 weeks, individual
clones designated as HEK-hTLR2-CD44, and HEK-hTLR2-pcDNA were
selected for expansion.
Cell injury induction
To investigate the effects of injured corneal cells in vitro, necrotic
corneal tissue extracts were prepared. Rat corneas were homogenized
in PBS (100ml per one cornea) using a motor-driven homogenizer
followed by five freeze-thaw cycles and incubated at 378C for 5 h
(Chen et al, 2007b). After centrifugation at 12,000 rpm for 5min, the
supernatants were obtained as necrotic extracts. Some of necrotic
extracts were heat-treated (1008C, 20min). Necrotic extracts were
incubated with the cells in culture at 1:10 dilution for 2 h.
To evaluate the effect of HSPB4, either antibodies to HSPB4 (10 or
50mg) (ab14821 and ab5595, Abcam) or isotype IgG antibodies were
added to the cultures.
To study the effects of small HSPs or SN, HSPB4, HSPB5, bB-crystallin
(0.001–10mg/ml, Enzo Life Sciences), or SN (0.1–10ng/ml) was added
to cultures of the cells, and the cultures were incubated for 2 h. Prior
to use, small HSPs were tested to be free of pyrogens after being
purified by endotoxin binding columns (EndoClear, blue) using the
Limulus amoebocyte lysate kit (Hycult Biotech Inc.) and E. coli HCP
ELISA kit (Cygnus Technologies). To additionally rule out the possibility
of bacterial or LPS contamination of small HSP preparations, all
experiments were performed in the presence of polymyxin B (10mg/ml)
(Sigma–Aldrich) for neutralization of LPS. Moreover, for additional
control experiments, small HSPs denatured by heat (1008C, 20min)
were used in parallel sets of experiments.
To examine the effect of TSG-6, 100 or 500 ng/ml of rhTSG-6 (R&D
Systems) was added to the cultures of the cells.
To determine whether keratocytes express small HSPs in response to
injury, either necrotic corneal extracts or H2O2 (100–500 nM) were
added to the cultures of keratocytes.www.embomolmed.org EMBO Mol Med 4, 435–448Myeloperoxidase (MPO) assay
For a quantitative measure of neutrophil infiltration, the cornea was
assayed for the MPO concentration (Rat MPO ELISA kit, HyCult
biotech) as we previously reported (Oh et al, 2010). For protein
extraction, the cornea was minced into small pieces and lysed in
150ml of tissue extraction reagent (Invitrogen) containing protease
inhibitor cocktail (Roche, Indianapolis, IN). The samples were sonicated
on ice using an ultrasound sonicator. After centrifugation at
12,000 rpm at 48C for 20min, the supernatant was collected and
assayed for levels of MPO.
Microarrays
For RNA extraction, the cornea was minced into small pieces, lysed in
600ml of RNA isolation reagent (RNA Bee, Tel-Test Inc., Friendswood, TX)
and homogenized using a motor-driven homogenizer. Total RNA was
then extracted using RNeasy Mini kit (Qiagen, Valencia, CA). RNA target
for microarrays was prepared using the 30 IVT Express Kit (Affymetrix,
Santa Clara, CA) according to manufacturer’s instructions starting with
200ng of total RNA. Total of 12.5mg of cRNA was hybridized onto rat
arrays (RG-230 2.0), and the arrays were stained, washed and scanned
for fluorescence. Microarray data were normalized and analysed using
the Partek Genomics Suite 6.4 (Partek, St. Louis, MO) and dChip software.
For comparative analysis, data were filtered based on fold changes of two
or more (either up- or down-regulated). For the hierarchical clustering
analysis, data were filtered using coefficient of variation higher than 0.6
and presence call of at least 33%. Filtered genes were hierarchically
clustered, and six clusters were selected on the similar level of hierarchy
and studied for enriched Gene Ontology tags based on hypergeometric
distribution. Data have been submitted to the ArrayExpress database.
Real-time RT PCR
Total RNA from the cornea or the cells was extracted as described above
and used to synthesize double-stranded cDNA by reverse transcription
(SuperScript III, Invitrogen). Real-time amplification was performed
(Taqman Universal PCR Master Mix, Applied Biosystems, Carlsbad, CA)
and analysed on an automated instrument (7900HT Fast Real-Time PCR
System, Applied Biosystems). PCR probe sets were commercially purchased
(Taqman Gene Expression Assay Kits, Applied Biosystems). For assays,
reactions were incubated at 508C for 2min, 958C for 10min and 40
cycles at 958C for 15 s followed by 608C for 1min. For normalization of
gene expression, 18S rRNA probe was used as an internal control.
Western blot
Clear lysates of protein from the cornea were prepared as described
above and measured for the concentration. A total of 10mg protein
was fractionated by SDS-PAGE on 10% bis–tris gel (Invitrogen),
transferred to nitrocellulose membrane (Invitrogen), and then blotted
with antibodies against SN (Phoenix Pharmaceuticals, Burlingame, CA)
or HSPB4 (ab14821, Abcam).
ELISAs
Protein was extracted from the cornea as described above and assayed
for levels of pro-inflammatory cytokines and chemokines with
commercial ELISA kits for IL-6, IL-1b and CXCL1/CINC-1 (Quantikine
kit, R&D Systems), and for CCL2/MCP-1 (Immunoassay Kit, Invitrogen).
For HSPB4 measurement, mouse monoclonal anti-rat antibody to
HSPB4 (ab14821, Abcam) was used as a capture antibody (4mg/ml), 2012 EMBO Molecular Medicine 445
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The paper explained
PROBLEM:
Sterile inflammation underlies many diseases. Specifically,
diseases of the cornea resulting from sterile inflammation range
from vision-threatening disorders (e.g. chemical burn) to quality-
of-life deteriorating diseases such as the dry eye syndrome that
affects nearly 10%of the U.S. population. For all these conditions,
the anti-inflammatory agents currently available are not
effective and often produce adverse effects. Hence, searching for
an effective therapeutic target for inflammation is critical. Here,
we have taken advantage of the unique features of the cornea to
analyse the process of sterile inflammation in detail and search
for the stimuli that initiate the inflammatory response.
RESULTS:
First, we found that neutrophil infiltration in sterile inflamma-
tion occurred in two distinct phases: early Phase I and late Phase
II. Next, we demonstrated that the neuropeptide SN was a major
signal for the initial Phase I inflammatory response in the cornea.
Also, the small heat shock protein HSPB4 was a principal signal
for a late Phase II. HSPB4 stimulated neutrophil infiltration in
Phase II by activating TLR2/NF-kB pathway in resident macro-
phages. We further showed that inhibition of the HSPB4/TLR2/
NF-kB axis in resident macrophages suppressed Phase II
inflammation in the cornea and rescued the cornea from vision-
threatening corneal opacity.
IMPACT:
The identification of the HSPB4/TLR2/NF-kB axis in resident
macrophages as the principal stimuli for the Phase II inflammatory
response has important implications as a potential therapy for
inflammatory diseases of the cornea. Also, the experimental
approachwe successfully used here can be applied to identify novel
therapeutic targets for inflammatory diseases in other tissues.
446and rabbit polyclonal anti-rat antibody to HSPB4 (ab5595, Abcam)
was used as a secondary antibody (400 ng/ml).
Release of HSPB4 in injured cornea
To measure the amount of HSPB4 released from the injured cornea,
the cornea was harvested immediately after injury and cultured in an
incubator at 378C with 5% CO2 for 12 h. Every 2 h, the culture
medium was changed, and the concentration of HSPB4 in the medium
during each time frame was measured by ELISA.
Histopathology
The cornea was excised after the animal was sacrificed and fixed in
10% paraformaldehyde. The cornea was cut into 4mm sections and
stained with the hematoxylin–eosin (H&E) or subjected to immunohis-
tochemistry. The formalin-fixed corneal section was deparaffinized with
ethanol. The antigen was retrieved using a steamer in epitope retrieval
solution (IHC WORLD, Woodstock, MD). The rabbit polyclonal anti-rat
antibody to neutrophil elastase (1:200) (ab21595, Abcam), the mouse
monoclonal anti-rat antibody to secretogranin II (1:200) (ab20245,
Abcam), or the mouse monoclonal anti-rat antibody to HSPB4 (1:200)
(ab14821, Abcam) were used as primary antibodies, and the anti-rabbit
IgG (1:5000) (Abcam) or the anti-mouse IgG (1:5000) (Abcam) used as
secondary antibodies. The DAPI solution (VECTASHIELD Mounting
Medium; Burlingame, CA) was used for counterstaining.
Aconitase activity assay
To evaluate the oxidative damage in the cornea by injury (Ma et al,
2009), loss of aconitase activity in corneal lysates was measured using
an Aconitase Assay Kit according to the manufacturer’s protocol
(Cayman Chemical Company, Ann Arbor, MI).
NF-kB translocation assays
Macrophages were plated in eight well chamber slides (Lab-Tek II
Chamber Slide; Nalge Nunc, Rochester, NY) and incubated for 1 h in 2012 EMBO Molecular Medicine0.2ml of 2% FBS in a-MEM with or without 10mg/ml HSPB4. The
cells were washed twice with PBS, fixed with 100% methanol for
5min, and blocked with Image-iTTM FX Signal Enhancer (Invitrogen).
The cells were then incubated with 1mg/ml of anti-NF-kB p65
antibody (ab16502, Abcam) in blocking buffer (5% BSA in PBS)
overnight at 48C. The samples were incubated for 1 h with the anti-
rabbit IgG (1:2000) (Alexa Fluor1 488, Invitrogen). The slides were
visualized with a fluorescent microscopy (Eclipse 80i, Nikon,
Melville, NY).
Statistical analysis
Comparisons of parameters among the groups were made by one-way
ANOVA using SPSS software (SPSS 12.0, Chicago, IL). Differences were
considered significant at p<0.05.Author contributions
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